Kezar Life Sciences, Inc. (KZR) Tops Q3 EPS by 5c

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q3 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue
• Macy's (M) Stock: Street Underestimates Earnings Pressure From Share Loss, Says Analyst